Hemogenyx secures clearance for pediatric enrolment in leukemia trial
(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received clearance to begin pediatric enrolment in its phase 1 trial of a leukemia treatment. Read More
| Price | 614.00p on 11-12-2025 at 09:05:01 |
|---|---|
| Change | 43.00p 7.53% |
| Buy | 614.00p |
| Sell | 570.00p |
| Last Trade: | Buy 582.00 at 614.00p |
| Day's Volume: | 5,675 |
| Last Close: | 571.00p |
| Open: | 620.00p |
| ISIN: | GB00BQVXM815 |
| Day's Range | 614.00p - 620.00p |
| 52wk Range: | 124.50p - 1,790.00p |
| Market Capitalisation: | £36.34m |
| VWAP: | 610.21515p |
| Shares in Issue: | 5.92m |
Sector: Medicine and Biotech
Hemogenyx Pharmaceuticals (HEMO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 582 | 614.00p | Automatic Execution |
08:59:17 - 11-Dec-25 |
| Buy* | 810 | 614.00p | Ordinary |
08:59:09 - 11-Dec-25 |
| Unknown* | 1 | 614.00p | OTC Trade |
08:57:39 - 11-Dec-25 |
| Buy* | 1 | 614.00p | Automatic Execution |
08:57:39 - 11-Dec-25 |
| Buy* | 1,630 | 610.00p | Ordinary |
08:53:19 - 11-Dec-25 |
| Sell* | 425 | 581.00p | Ordinary |
08:48:13 - 11-Dec-25 |
| Sell* | 17 | 570.00p | SI Trade |
08:16:23 - 11-Dec-25 |
| Buy* | 87 | 610.00p | Ordinary |
08:15:32 - 11-Dec-25 |
| Buy* | 100 | 610.00p | Ordinary |
08:13:43 - 11-Dec-25 |
| Buy* | 2,000 | 614.652p | Ordinary |
08:10:51 - 11-Dec-25 |
Hemogenyx Pharmaceuticals (HEMO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 8th Dec 2025 12:48 pm | RNS | Holding(s) in Company |
| 28th Nov 2025 7:00 am | RNS | Total Voting Rights |
| 19th Nov 2025 11:47 am | RNS | Publication of Prospectus |
| 29th Oct 2025 7:00 am | RNS | Clinical Trial Update and Grant of Share Awards |
| 6th Oct 2025 7:00 am | RNS | Clearance to Initiate Pediatric Enrolment |
| 30th Sep 2025 7:00 am | RNS | Half-year Report |
| 30th Sep 2025 7:00 am | RNS | Total Voting Rights |
| 23rd Sep 2025 7:00 am | RNS | Hemogenyx Signs Letter of Intent |
| 18th Sep 2025 1:16 pm | RNS | Holding(s) in Company |
| 17th Sep 2025 7:00 am | RNS | Third Patient Safety |